On the pathogenesis of bleomycin lung toxicity
- PMID: 83311
Item in Clipboard
On the pathogenesis of bleomycin lung toxicity
Int J Clin Pharmacol Biopharm.
1978 Dec.
Abstract
Bleomycin is potentially capable of inducing a diffuse interstitial fibrosis of the lung, the pathogenesis of which has not yet been elucidated. The authors have demonstrated that after 48 hr of acute treatment, morphological and functional modifications could be seen in type II pneumocytes, which are responsible for surfactant production. This might be the earliest stage of pulmonary damage.
Similar articles
-
Bleomycin lung damage: the pathology and nature of the lesion.Br J Dis Chest. 1978 Oct;72(4):321-6. Br J Dis Chest. 1978. PMID: 83150
-
Experimentally induced bleomycin sulfate pulmonary toxicity: histopathologic and ultrastructural study in the pheasant.Arch Pathol Lab Med. 1977 May;101(5):248-54. Arch Pathol Lab Med. 1977. PMID: 66910
-
Bleomycin and pulmonary toxicity.Neth J Med. 1985;28(11):516-23. Neth J Med. 1985. PMID: 2417127 Review. No abstract available.
-
Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice.Lab Invest. 1976 Dec;35(6):558-68. Lab Invest. 1976. PMID: 62893
-
[Pulmonary lesions associated with chemotherapy for cancer (author's transl)].Rinsho Byori. 1974 Aug;22(Suppl):159-67. Rinsho Byori. 1974. PMID: 4139293 Review. Japanese. No abstract available.
Cited by
-
Experimental bleomycin lung in mice. A contribution to the pathogenesis of pulmonary fibrosis.Lung. 1983;161(3):133-46. doi: 10.1007/BF02713855. Lung. 1983. PMID: 6192292 No abstract available.
-
Lung damage from cytotoxic drugs.Cancer Chemother Pharmacol. 1980;4(1):17-27. doi: 10.1007/BF00255453. Cancer Chemother Pharmacol. 1980. PMID: 6153937 Review.